Janet Woodcock, acting FDA commissioner (Bill Clark/CQ Roll Call via AP Images)
FDA head Janet Woodcock raises patent-related concerns to PTO director
While matters of drug pricing may not fall squarely under the FDA’s purview, acting FDA commissioner Janet Woodcock made clear the agency’s concerns around patents …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
